Abstract
Presently, our work, as well as that of other authors, has produced convincing evidence in favor of the idea that disturbances in hormonal signaling systems are one of the main causes of the development of pathological alterations and complications in diabetes. However, the molecular mechanisms underlying these disturbances remain practically unstudied, particularly in insulin-independent type 2 diabetes. Using a neonatal streptozotocin model of type 2 diabetes, whose duration was either 80 or 180 days, we studied changes in the functional activity of components of the hormone-regulated adenylyl cyclase (AC) signaling system in the myocardium and brain striatum of diabetic rats as compared with control animals. In diabetes, the Gi-realized process of transduction of the hormonal signal inhibiting AC activity has been shown to be markedly impaired. This is manifested as a decrease of the inhibitory effect of hormones on AC activity and an attenuation of their stimulation of the G-protein’s GTP-binding activity. In the case of noradrenaline (myocardium), the inhibitory pathway of the AC system regulation is completely suppressed, while the stimulatory pathway is preserved. An increase in the duration of diabetes development from 80 to 180 days leads to some decrease in the transduction of hormonal signals realized via Gi-proteins. The stimulatory effects of biogenic amines and relaxin on AC activity and GTP binding in the myocardium and brain of diabetic rats change relatively little, both in the 80-and in the 180-day diabetes. Thus, in the experimental type 2 diabetes, disturbances in Gi-protein coupled signal cascades are primarily observed, through which hormones realize their inhibition of AC activity.
Similar content being viewed by others
Abbreviations
- AR:
-
adrenergic receptor
- AC:
-
adenylyl cyclase
- AC:
-
system-adenylyl cyclase signaling system
- STZ:
-
streptozotocin
- Gs-and Gi-proteins:
-
heterotrimeric G-proteins of the stimulatory and inhibitory type
References
Begin-Heick, N., Liver β-Adrenergic Receptors, G Proteins, and Adenylyl Cyclase Activity in Obesity-diabetes Syndromes, Am. J. Physiol., 1994, vol. 266, pp. 1664–1672.
Breitweg-Lehmann, E., Czupalla, C., Storm, R., Kudlacek, O., Schunack, W., Freissmuth, M., and Nurnberg, B, Activation and Inhibition of G Protein by Lipoamines, Mol. Pharmacol., 2002, vol. 61, pp. 628–636.
Bushfield, M., Griffiths, S.L., Murphy, G.J., Pyne, N.J., Knowler, J.T., Milligan, G., Parker, P.J., Mollner, S., and Houslay, M.D. Diabetes-induced Alterations in the Expression, Functioning and Phosphorylation State of the Inhibitory Guanine Nucleotide Regulatory Protein Giα-2 in hepatocytes, Biochem. J., 1990, vol. 271, pp. 365–372.
Caro, J.F., Raju, M.S., Caro, M., Lynch, C.J., Poulos, J., Exton, J.H., and Thakkar, J.K., Guanine Nucleotide Binding Proteins in Liver from Obese Humans with and without Type II Diabetes: Evidence for Altered “Crosstalk” between the Insulin Receptor and Gi proteins, J. Cell. Biochem., 1994, vol. 54, pp. 309–319.
Chen, J.F., Guo, J.H., Moxham, C.M., Wang, H.Y., and Malbon, C.C., Conditional, Tissue-specific Expression of Q205L Gαi2 in vivo Mimics Insulin Action, J. Mol. Med., 1997, vol. 75, pp. 283–289.
Dincer, D.U., Bidasee, K.R., Guner, S., Tay, A., Ozcelikay, T., and Altan, V.M. The Effect of Diabetes on Expression of β1-, β2-and β3-Adrenoreceptors in Rat Hearts, Diabetes, 2001, vol. 50, pp. 455–461.
Fernandez-Real, J.M., Penarroja, G., Richart, C., Castro, A., Vendrell, J., Broch, M., Lopez-Bermejo, A., and Ricart, W., G Protein β3 Gene Variant, Vascular Function, and Insulin Sensitivity in Type 2 Diabetes, Hypertension, 2003, vol. 41, pp. 124–129.
Gando, S., Hattori, Y., Akaishi, Y., Nishihira, J., and Kanno, M., Impaired Contractile Response to Beta Adrenoreceptor Stimulation in Diabetic Rat Hearts: Alterations in Beta Adrenoreceptors-G protein-adenylate Cyclase System and Phospholamban Phosphorylation, J. Pharmacol. Exp. Ther., 1997, vol. 282, pp. 475–484.
Gauthier, C., Tavernier, G., Charpentier, F., Langin, D., Le Marec, H., Functional β3-AR in the Human Heart, J. Clin. Invest., 1996, vol. 98, pp. 556–562.
Gawler, D., Milligan, G., Spiegel, A.M., Unson, C.H., and Houslay, M.D., Abolition of the Expression of the Inhibitory Guanine Nucleotide Regulatory Protein Gi Activity in Diabetes, Nature, 1987, vol. 327, pp. 229–232.
Hadjiconstantinou, M., Qu, Z.K., Moroi-Fetters, S.E., and Neff, N.H., Apparent Loss of Gi Protein Activity in the Diabetic Retina, Eur. J. Pharmacol., 1988, vol. 149, pp. 193–194.
Hajos, F., An Improved Method for the Preparation of Synaptosomal Fractions in High Purity, Brain Res., 1975, vol. 93, pp. 485–489.
Hashim, S., Li, Y., and Anand-Srivastava, M.B., G-Protein-linked Cell Signaling and Cardiovascular Functions in Diabetes/Hyperglycemia, Cell. Biochem. Biophys., 2006, vol. 44, pp. 51–64.
Hashim, S., Li, Y., Nagakura, A., Takeo, S., and Anand-Srivastava, M.B., Modulation of G-Protein Expression and Adenylyl Cyclase Signaling by High Glucose in Vascular Smooth Muscle, Cardiovasc. Res., 2004, vol. 63, pp. 709–718.
Hashim, S., Li, Y.Y., Wang, R., and Anand-Srivastava, M.B., Streptozotocin-induced Diabetes Impairs G-Protein Linked Signal Transduction in Vascular Smooth Muscle, Mol. Cell. Biochem., 2002, vol. 240, pp. 57–65.
Hattori, Y., Matsuda, N., Sato, A., Watanuki, S., Tomioka, H., Kawasaki, H., and Kanno, M., Predominant Contribution of the G Protein-mediated Mechanism to NaF-induced Vascular Contractions in Diabetic Rats: Association with an Increased Level of Expression, J. Pharmacol. Exp. Ther., 2000, vol. 292, pp. 761–768.
Hemmings, S.J. and Spafford, D., Neonatal STZ Model of Type II Diabetes Mellitus in the Fischer 344 Rat: Characteristics and Assessment of the Status of the Hepatic Adrenergic Receptors, Int. J. Biochem. Cell Biol., 2000, vol. 32, pp. 905–919.
Higashijima, T., Burnier, J., and Ross, E.M., Regulation of Gi and Go by Mastoparan, Related Amphiphilic Peptides and Hydrophobic Amines, J. Biol. Chem., 1990, vol. 265, pp. 14176–14186.
Kidwai, A.M., Radcliffe, A.M., Lee, E.V., and Daniel, E.E., Isolation and Properties of Skeletal Muscle Membrane, Biochim. Biophys. Acta, 1973, vol. 289, pp. 593–607.
Kowluru, A., Kowluru, R.A., and Yamaraki, A., Functional Alterations of G-Proteins in Diabetic Rat Retina: a Possible Explanation for the Early Visual Abnormalities in Diabetes Mellitus, Diabetologia, 1992, vol. 35, pp. 624–631.
Kuznetsova, L., Plesneva, S., Shpakov, A., and Pertseva, M., Functional Defects in Insulin and Relaxin Adenylyl Cyclase Signaling Systems in Myometrium of Pregnant Women with Type 1 Diabetes, Ann. N.Y. Acad. Sci., 2005, vol. 1041, pp. 446–448.
Livingstone, C., McLellan, A.R., McGregor, M., Wilson, A., Connell, J.M.C., Small, M., Milligan, G., Paterson, K.R., and Houslay, M.D., Altered G-Protein Expression and Adenylate Cyclase Activity in Platelets of Non-insulin-dependent (NIDDM) Male Subjects, Biochim. Biophys. Acta, 1991, vol. 1096, pp. 127–133.
Malbon, C.C., Insulin Signalling: Putting the “G-” in Protein-protein Interactions, Biochem. J., 2004, vol. 380, pp. 11–12.
Matsuda, N., Hattori, Y., Gando, S., Akaishi, Y., Kemnotsu, O., and Kanno, M., Diabetes-induced Downregulation of β1-AR mRNA Expression in Rat Heart. Biochem. Pharmacol., 1999, vol. 58, pp. 881–885.
Matsumoto, T., Wakabayashi, K., Kobayashi, T., and Kamata, K., Functional Changes in Adenylyl Cyclases and Associated Decreases in Relaxation Response in Mesenteric Arteries from Diabetic Rats, Am. J. Physiol. Heart Circ. Physiol., 2005, vol. 89, pp. 2234–2243.
McIntire, W.E., MacCleery, G., and Garrison, J.C., The G Protein (Subunit Is a Determinant in the Coupling of Gs to the β1-Adrenergic and A2a Adenosine Receptors, J. Biol. Chem., 2001, vol. 276, pp. 15801–15809.
Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., and Caron, M.G., Dopamine Receptors: from Structure to Function, Physiol. Rev., 1998, vol. 78, pp. 189–225.
Moxham, C.M., and Malbon, C.C., Insulin Action Impaired by Deficiency of the G-Protein Subunit Giα2, Nature, 1996, vol. 379, pp. 840–844.
Nielsen, M.D., Chan, G.C.K., Poser, S.W., and Storm, D.R., Differential Regulation of Type I and Type VIII Ca{sr2+}-stimulated Adenylyl Cyclases by Gi-coupled Receptors in vivo, J. Biol. Chem., 1996, vol. 271, pp. 33308–33316.
Palmer, T.M., Taberner, P.V., and Houslay M.D., Alterations in G-protein Expression, Gi Function and Stimulatory Receptor-mediated Regulation of Adipocyte Adenylyl Cyclase in a Model of Insulin-resistant Diabetes with Obesity, Cell. Signall., 1992, vol. 4, pp. 365–377.
Panchenko, M.P., Hoffenberg, S.I., and Tkachuk, V.A., Purification and Some Properties of GTP-binding Proteins from Pig Heart Plasma Membranes, Biochim. Biophys. Acta, 1987, vol. 46, pp. 452–455.
Plesneva, S.A., Shpakov, A.O., Kuznetsova, L.A., and Pertseva, M.N., A Dual Role of Protein Kinase C in Insulin Signal Transduction via Adenylyl Cyclase Signaling System in Muscle Tissues of Vertebrates and Invertebrates, Biochem. Pharmacol., 2001, vol. 61, pp. 1277–1291.
Richardson, M.R., Kilts, J.D., and Kwatra, M.M., Increased Expression of Gi Coupled Muscarinic Acetylcholine Receptor and Gi in Atrium of Elderly Diabetic Subjects, Diabetes, 2004, vol. 53, pp. 2392–2396.
Salomon, Y., Londos, C., and Rodbell, M.A., Highly Sensitive Adenylate Cyclase Assay, Anal. Biochem., 1974, vol. 58, pp. 541–548.
Schreff, M., Schulz, S., Handel, M., Keilhoff, G., Braun, H., Pereira, G., Klutzny, M., Schmidt, H., Wolf, G., and Hollt, V., Distribution, Targeting, and Internalization of the sst4 Somatostatin Receptor in Rat Brain, J. Neurosci., 2000, vol. 20, pp. 3785–3797.
Shpakov, A.O., Gur’yanov, I.A., Kuznetsova, L.A., Plesneva, S.A., Korol’kov, B.I., Pertseva, M.N., and Vlasov, G.P., Use of C-Terminal Peptides of G-Protein α-Subunuts for Study of Their Functional Coupling to Biogenic Amine Receptors in Rat and Mollusc Tissues, Biol. Membrany, 2004, vol. 21, no. 6, pp. 441–450.
Shpakov, A.O., Kuznetsova, L.A., Plesneva, S.A., and Pertseva, M.N., Molecular Mechanisms of Change of Sensitivity of Adenylyl Cyclase Signal System to Biogenic Amines in Streptozotocin Diabetes, Byull. Exp. Biol. Med., 2005a, vol. 140, no. 9, pp. 286–290.
Shpakov, A.O., Kuznetsova, L.A., Plesneva, S.A., Gur’yanov, I.A., and Pertseva, M.N., Molecular Causes of Change of Sensitivity of the Cardiac Muscle Adenylyl Cyclase Signal System to Biogenic Amines in Experimental Streptozotocin Diabetes, Tsitologya, 2005b, vol. 47, no. 6, pp. 540–548.
Shpakov, A.O., and Pertseva, M.N., Molecular Mechanisms of Action of Mastoparan on G-Proteins in Tissues of Vertebrae and Invertebrate Animals, Byull. Exp. Biol. Med., 2006, vol. 141, no. 3, pp. 273–277.
Song, X., Zheng, X., Malbon, C.C., and Wang, H.. Gαi2 Enhances in vivo Activation of and Insulin Signaling to GLUT4, J. Biol. Chem., 2001, vol. 276, pp. 34651–34658.
Wichelhaus, A., Russ, M., Petersen, S., and Eckel, J.G., Protein Expression and Adenylate Cyclase Regulation in Ventricular Cardiomyocytes from STZ-diabetic Rats, Am. J. Physiol., 1994, vol. 267, pp. 548-555.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.O. Shpakov, L.A. Kuznetsova, S.A. Plesneva, M.N. Pertseva, 2007, published in Tsitologiya, Vol. 49, No. 4, 2007
Rights and permissions
About this article
Cite this article
Shpakov, A.O., Kuznetsova, L.A., Plesneva, S.A. et al. Disturbance of transduction of adenylyl cyclase-inhibiting hormonal signaling in the myocardium and brain of rats with experimental type 2 diabetes. Cell Tiss. Biol. 1, 343–351 (2007). https://doi.org/10.1134/S1990519X07040062
Received:
Issue Date:
DOI: https://doi.org/10.1134/S1990519X07040062